Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
83-0060 in healthy volunteers
NCT06402136Phase 1Completed
- Sponsor
- Traws Pharma, Inc.
- Start
- Apr 2024
- Primary completion
- Aug 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ratutrelvir (8 arms), sponsored by Traws Pharma, Inc. Primary endpoints: Adverse Events at 17 days, Drug-related Adverse Events at 17 days and 2 more. Started Apr 2024; status: completed.
02
Drugs
ratutrelvir
Beyond the preview
Go deeper on NCT06402136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06402136.